EMILY TIMMONS: Open Payments
NPI 1174248488 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 22 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $611
Food & beverage: $451Education: $160
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $156 |
| GENZYME CORPORATION | 3 | $88 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Arcutis Biotherapeutics, Inc. | 1 | $76 |
| ABBVIE INC. | 2 | $38 |
| Organon LLC | 3 | $29 |
| Incyte Corporation | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $19 |
| Almirall LLC | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $18 |
Products named: DUPIXENT, TREMFYA, Zoryve, SKYRIZI, OPZELURA, NEMLUVIO, Klisyri, Winlevi.
Industry payments across CO — which companies pay providers there.
